Enabling the public's earlyaccess to good medicines
Next steps
Porton PharmaTech is a European subsidiary of Porton Pharma Solutions Ltd.
An internationally recognized pharmaceutical contract development and manufacturing organization
(CDMO) in drug substance development and manufacturing.
Porton PharmaTech is currently undergoing development, with new constructions and facility enhancements underway.
New facilities include space designated for research and development laboratories and a
KILOLAB startup from Q2’24 onwards.
One of the key highlights is the on-going green field investment in a PILOT PLANT designed
to host capacity of different unit operations trains, including finalization, QC laboratories
and Process Safety Laboratory. The operations are scheduled to start from Q2’25
with qualification of GMP activities by Q4’26.
KILOLAB startup
Q2
2024
PILOT PLANT
Q2
2025
Qualification of GMP activities
Q4
2026
Our global network
We have 5000+ skilled employees working across 20+ sites around the globe